Company intelligence
EarliPoint Health
FDA-Cleared eye-tracking technology to assist clinicians in assessing autism.
Medical Equipment Manufacturing
Atlanta, US
37 employees
Founded 2019
2 public signals
About EarliPoint Health
The EarliPoint System device is indicated for use as a tool to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children ages 16 months through 95 months who are at risk based on concerns identified by a parent, caregiver, or healthcare provider (Not for direct consumer purchase; clinician use only).
Verified activity
Signals from EarliPoint Health
2 published signals
Presence & Recognition
EarliPoint Health Chief Medical Officer Cheryl T. joined ABS Kids on the Autism Weekly podcast to discuss why families wait for an autism evaluation and how eye-tracking technology is changing that.
Reported by EarliPoint Health
Research & Knowledge
EarliPoint Health published an article offering a practical overview for providers regarding scope of practice, clinical expertise, state regulations, and payer requirements for autism diagnosis and referral.
Reported by EarliPoint Health